Background: Asthma is a known risk factor for atrial fibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
Objective: To evaluate the impact of asthma and its severity on AF recurrence following ablation.
J Arrhythm
December 2024
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint expert consensus document was issued, guiding healthcare professionals involved in catheter or surgical AF ablation. Mounting research evidence and technological advances have resulted in a rapidly changing landscape in the field of catheter and surgical AF ablation, thus stressing the need for regularly updated versions of this partnership which were issued in 2012 and 2017.
View Article and Find Full Text PDFCardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Arrhythmic manifestations span the spectrum of innocuous and benign to life-threatening and deadly. Various pathophysiological mechanisms have been proposed.
View Article and Find Full Text PDFJ Interv Card Electrophysiol
August 2024
Heart Rhythm
September 2024
Europace
March 2024
J Interv Card Electrophysiol
March 2024
J Cardiovasc Electrophysiol
January 2024
Comput Methods Programs Biomed
November 2023
JACC Clin Electrophysiol
September 2023